From Injections to Pills: Breaking Down the New Oral GLP-1 Data

Podcast: Docs Who Lift · Docs Who Lift

Opublikowano: 2025-10-23

Show Notes: In this episode of Docs Who Lift, the Nadolsky brothers welcome back Dr. Sean Wharton, clinical trialist and one of the leading researchers behind the next generation of oral GLP-1 medications. Together, they break down: The OASIS-4 trial results on 25mg oral semaglutide and how it stacks up to injectable Wegovy How orforglipron, Eli Lilly’s new small-molecule GLP-1, differs from peptide-based drugs Why these new therapies could make weight management more accessible and affordable The fascinating pharmacology behind “snack molecules” and small-molecule receptor agonists Common miscon...